OwkinZero: Accelerating Biological Discovery with AI
While large language models (LLMs) are rapidly advancing scientific research, they continue to struggle with core biological reasoning tasks essential for translational and biomedical discovery. To address this limitation, we created and curated eight comprehensive benchmark datasets comprising over 300,000 verifiable question-and-answer pairs, each targeting critical challenges in drug discovery including target druggability, modality suitability, and drug perturbation effects. Using this resource, we developed the OwkinZero models by post-training open-source LLMs through a Reinforcement Learning from Verifiable Rewards strategy. Our results demonstrate that specialized 8-32B OwkinZero models substantially outperform larger, state-of-the-art commercial LLMs on these biological benchmarks. Remarkably, we uncover evidence of a key aspect of generalization: specialist models trained on a single task consistently outperform their base models on previously unseen tasks. This generalization effect is further amplified in our comprehensive OwkinZero models, which were trained on a mixture of datasets and achieve even broader cross-task improvements. This study represents a significant step toward addressing the biological reasoning blind spot in current LLMs, demonstrating that targeted reinforcement learning on carefully curated data can unlock generalizable performance in specialized models, thereby accelerating AI-driven biological discovery.
Code (0)
등록된 구현이 없습니다.
Tasks
Reinforcement LearningDrug DiscoverySimilar Papers 제목 키워드 기반
CellFluxRL: Biologically-Constrained Virtual Cell Modeling via Reinforcement Learning
Building virtual cells with generative models to simulate cellular behavior in silico is emerging as a promising paradigm for accelerating drug discovery. However, prior image-based generative approaches can produce impl…
Reinforcement LearningDrug DiscoveryBioDiscoveryAgent: An AI Agent for Designing Genetic Perturbation Experiments
Agents based on large language models have shown great potential in accelerating scientific discovery by leveraging their rich background knowledge and reasoning capabilities. In this paper, we introduce BioDiscoveryAgen…
AI AgentBayesian Optimizationscientific discoverySCORCH2: a generalised heterogeneous consensus model for high-enrichment interaction-based virtual screening
The discovery of effective therapeutics remains a complex, costly, and time-consuming endeavor, characterized by high failure rates and significant resource investments. A central bottleneck in early-stage drug discover…
Drug DiscoveryDrugPlayGround: Benchmarking Large Language Models and Embeddings for Drug Discovery
Large language models (LLMs) are in the ascendancy for research in drug discovery, offering unprecedented opportunities to reshape drug research by accelerating hypothesis generation, optimizing candidate prioritization,…
Drug DiscoveryEvaluating the Potential of Leading Large Language Models in Reasoning Biology Questions
Recent advances in Large Language Models (LLMs) have presented new opportunities for integrating Artificial General Intelligence (AGI) into biological research and education. This study evaluated the capabilities of lead…
Logical ReasoningMultiple-choice